Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases

NCT06500455 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT06500455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06500455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 12, 2024
Completion date
June 30, 2033
Enrollment
274 (actual)
Sites
270

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, metastatic breast carcinoma, metastatic digestive system carcinoma, metastatic lung non-small cell carcinoma, metastatic malignant neoplasm in the brain, metastatic malignant solid neoplasm, metastatic melanoma, metastatic renal cell carcinoma, stage iv lung cancer ajcc v8, stage iv renal cell cancer ajcc v8